Archives

Ivosidenib is approved by FDA for myelodysplastic syndromes

Ivosidenib is approved by FDA for myelodysplastic syndromes

November 24th, 2023 MDS

Nov 2023: The Food and Drug Administration (FDA) approved Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) in November 2023 for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) who have a suscepti.... Read More

Neoadjuvant/ adjuvant pembrolizumab is approved by the FDA for resectable non-small cell lung cancer

Neoadjuvant/ adjuvant pembrolizumab is approved by the FDA for resectable non-small cell lung cancer

November 24th, 2023 Lung cancer

Nov 2023: Pembrolizumab (Keytruda, Merck) was granted approval by the Food and Drug Administration (FDA) as a neoadjuvant treatment in combination with platinum-containing chemotherapy and as a post-surgical adjuvant treatment for resectable no.... Read More

Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma

Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma

November 24th, 2023 Melanoma

Nov 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Company) was granted approval by the Food and Drug Administration as an adjuvant therapy for Stage IIB/C melanoma in patients 12 years and older who had undergone complete resection. In the r.... Read More

FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation

Encorafenib with binimetinib is approved by the FDA for treatment of metastatic non-small cell lung cancer with a BRAF V600E mutation

November 24th, 2023 Lung cancer

The Food and Drug Administration (FDA) approved Encorafenib (Braftovi, Array BioPharma Inc., a wholly owned subsidiary of Pfizer) and binimetinib (Mektovi, Array BioPharma Inc.) in November 2023 as medicines that can be used to treat adults wit.... Read More

Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia

Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia

November 23rd, 2023 Blood cancer

Nov 2023: For paediatric patients aged one year and above with chronic phase (CP) Ph+ chronic myelogenous leukaemia (CML), either newly diagnosed (ND) or resistant or intolerant (R/I) to previous therapy, the Food and Drug Administration has ap.... Read More

New and updated indications are approved by FDA for temozolomide under Project Renewal

New and updated indications are approved by FDA for temozolomide under Project Renewal

November 23rd, 2023 Cancer

Nov 2023: Under Project Renewal, an Oncology Centre of Excellence (OCE) initiative aimed at updating labelling information for older oncology drugs to ensure information is clinically meaningful and scientifically up-to-date, the Food and Drug .... Read More

Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma

Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma

November 23rd, 2023 Liver cancer

Nov 2023: The Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) as a liver-directed treatment for adult patients with uveal melanoma who have unresectable hepatic metastas.... Read More

Elranatamab-bcmm receives approval for the treatment of multiple myeloma

Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma

November 23rd, 2023 Myeloma

Nov 2023: Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by the Food and Drug Administration for adults with relapsed or refractory mult.... Read More

How Does CAR T Therapy Works And Transforming Cancer Treatment?

November 18th, 2023 Blood cancer, Cancer treatment in India, Leukemia, Lymphoma

Discover the science behind CAR T Cell therapy treatment in India! Explore how this revolutionary treatment transforms your immune cells into cancer fighters. Read our blog now to learn more about this miraculous therapy and how it can help can.... Read More

Is CAR T-Cell Therapy Available In India?

November 18th, 2023 Cancer, Cancer treatment in India, Leukemia, Lymphoma, Uncategorized

Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope in your fight against cancer, a treatment that uses the power of your body's own immune system to target and destroy cance.... Read More